Key facts
- It has raised $71.1M across 8 recorded rounds; the latest was Later Stage VC (Series C1) ($33.6M) in Sep 2020.
- AZTherapies has filed 11 Form Ds with the SEC since 2015, most recently Sep 2020 ($14.8M sold to 59 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 8 rounds
- ·Watchlist + deal alerts for AZTherapies
Create free account
No card required
Funding rounds
8 roundsSep 2020Later Stage VC (Series C1)$33.6M▮
Jan 2020Later Stage VC (Series C)$37.5M▮
About AZTherapies
- Industry
- Drug Discovery
PA Mark — not yet priced
AZTherapies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in AZTherapies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on AZTherapies in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.